Identifying a combined biomarker for bisphosphonate-related osteonecrosis of the jaw

Ki Yeol Kim, Xianglan Zhang, In Ho Cha

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Background: For this study, the aim was to identify combined biomarkers associated with bisphosphonate-related osteonecrosis of the jaw (BRONJ). Materials and Methods: Microarray data for GSE7116 were downloaded from the Gene Expression Omnibus database, which contains 26 samples, including without ONJ, and 5 healthy volunteers. The combined biomarkers were identified using principal component analysis, and the pathway enrichment analyses were performed using the DAVID online tool. Results: Two hundred differently expressed genes between groups were detected according to the significances. From functional annotation, Y-box binding protein 1 and heterogeneous nuclear ribonucleoprotein C were found to be included in the most significant 10 pathways. Ten combined gene sets were identified that were effective in classifying multiple myeloma (MM) with ONJ and MM without ONJ. Conclusion: Identifying combined gene expression profiles is expected to contribute to more personalized management of BRONJ and to improve existing therapies, and it will be helpful in finding new therapies by identifying more predictive biomarkers.

Original languageEnglish
Pages (from-to)191-198
Number of pages8
JournalClinical Implant Dentistry and Related Research
Volume20
Issue number2
DOIs
Publication statusPublished - 2018 Apr

Fingerprint

Bisphosphonate-Associated Osteonecrosis of the Jaw
Biomarkers
Multiple Myeloma
Heterogeneous-Nuclear Ribonucleoprotein Group C
Y-Box-Binding Protein 1
Principal Component Analysis
Transcriptome
Genes
Healthy Volunteers
Databases
Gene Expression
Therapeutics

All Science Journal Classification (ASJC) codes

  • Oral Surgery
  • Dentistry(all)

Cite this

@article{0000c8b9ce9946ce88ba9fc48f4f4337,
title = "Identifying a combined biomarker for bisphosphonate-related osteonecrosis of the jaw",
abstract = "Background: For this study, the aim was to identify combined biomarkers associated with bisphosphonate-related osteonecrosis of the jaw (BRONJ). Materials and Methods: Microarray data for GSE7116 were downloaded from the Gene Expression Omnibus database, which contains 26 samples, including without ONJ, and 5 healthy volunteers. The combined biomarkers were identified using principal component analysis, and the pathway enrichment analyses were performed using the DAVID online tool. Results: Two hundred differently expressed genes between groups were detected according to the significances. From functional annotation, Y-box binding protein 1 and heterogeneous nuclear ribonucleoprotein C were found to be included in the most significant 10 pathways. Ten combined gene sets were identified that were effective in classifying multiple myeloma (MM) with ONJ and MM without ONJ. Conclusion: Identifying combined gene expression profiles is expected to contribute to more personalized management of BRONJ and to improve existing therapies, and it will be helpful in finding new therapies by identifying more predictive biomarkers.",
author = "Kim, {Ki Yeol} and Xianglan Zhang and Cha, {In Ho}",
year = "2018",
month = "4",
doi = "10.1111/cid.12569",
language = "English",
volume = "20",
pages = "191--198",
journal = "Clinical Implant Dentistry and Related Research",
issn = "1523-0899",
publisher = "Wiley-Blackwell",
number = "2",

}

Identifying a combined biomarker for bisphosphonate-related osteonecrosis of the jaw. / Kim, Ki Yeol; Zhang, Xianglan; Cha, In Ho.

In: Clinical Implant Dentistry and Related Research, Vol. 20, No. 2, 04.2018, p. 191-198.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Identifying a combined biomarker for bisphosphonate-related osteonecrosis of the jaw

AU - Kim, Ki Yeol

AU - Zhang, Xianglan

AU - Cha, In Ho

PY - 2018/4

Y1 - 2018/4

N2 - Background: For this study, the aim was to identify combined biomarkers associated with bisphosphonate-related osteonecrosis of the jaw (BRONJ). Materials and Methods: Microarray data for GSE7116 were downloaded from the Gene Expression Omnibus database, which contains 26 samples, including without ONJ, and 5 healthy volunteers. The combined biomarkers were identified using principal component analysis, and the pathway enrichment analyses were performed using the DAVID online tool. Results: Two hundred differently expressed genes between groups were detected according to the significances. From functional annotation, Y-box binding protein 1 and heterogeneous nuclear ribonucleoprotein C were found to be included in the most significant 10 pathways. Ten combined gene sets were identified that were effective in classifying multiple myeloma (MM) with ONJ and MM without ONJ. Conclusion: Identifying combined gene expression profiles is expected to contribute to more personalized management of BRONJ and to improve existing therapies, and it will be helpful in finding new therapies by identifying more predictive biomarkers.

AB - Background: For this study, the aim was to identify combined biomarkers associated with bisphosphonate-related osteonecrosis of the jaw (BRONJ). Materials and Methods: Microarray data for GSE7116 were downloaded from the Gene Expression Omnibus database, which contains 26 samples, including without ONJ, and 5 healthy volunteers. The combined biomarkers were identified using principal component analysis, and the pathway enrichment analyses were performed using the DAVID online tool. Results: Two hundred differently expressed genes between groups were detected according to the significances. From functional annotation, Y-box binding protein 1 and heterogeneous nuclear ribonucleoprotein C were found to be included in the most significant 10 pathways. Ten combined gene sets were identified that were effective in classifying multiple myeloma (MM) with ONJ and MM without ONJ. Conclusion: Identifying combined gene expression profiles is expected to contribute to more personalized management of BRONJ and to improve existing therapies, and it will be helpful in finding new therapies by identifying more predictive biomarkers.

UR - http://www.scopus.com/inward/record.url?scp=85038429948&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85038429948&partnerID=8YFLogxK

U2 - 10.1111/cid.12569

DO - 10.1111/cid.12569

M3 - Article

C2 - 29266738

AN - SCOPUS:85038429948

VL - 20

SP - 191

EP - 198

JO - Clinical Implant Dentistry and Related Research

JF - Clinical Implant Dentistry and Related Research

SN - 1523-0899

IS - 2

ER -